No World Borders to Present at Atlanta ICD-10 Conference

HIPAA 5010 impact assessment, remediation, testing
HIPAA 5010 impact assessment, remediation, testing

On February 18th and 19th Michael Arrigo, CEO of No World Borders, Inc. will be participating in Health Care Education Associates’ “Strategically Transitioning to ICD-10 for Providers & Plans,” a health care industry conference focused on helping the health care industry move to the new electronic health record standards.

The conference will cover both the data interchange standard HIPAA X12 5010 and the companion medical claims coding standard ICD-10. Over 20 industry experts from leading health consulting and technology solutions firms will be participating.

“Moving from ICD-9 to ICD-10 coding is one of the toughest challenges facing the healthcare industry today, said Michael Arrigo. “This conference will help health plans and providers prepare now by learning the key steps in making the transition, which many describe as a bigger effort for the health care industry than addressing Y2K.” he continued.

Mr. Arrigo will make two presentations covering:

  • Migration from 4010 to 5010: Finalizing the Details
  • Implementing & Optimizing a New Strategic Business Infrastructure for ICD-10

The conference will focus on these topics:

  • How to leverage ICD-10 to drive efficiency in your organization
  • Ways to best finalize the details in moving from HIPAA 4010 to 5010
  • Impacted functions in your organization and how to prepare them
  • Best practices in making the transition to ICD-10
  • Benchmarks-how far along should you be…and by when?
  • How to train the trainers to train your staff
  • Revenue & reimbursement implications for ICD-10

Some of the specific topics geared to health plans include:

  • How each department of your plan will be affected…and how to prepare
  • How to design and redesign procedures for ICD-10
  • How to manage your vendors

Specific topics addressed to providers include:

  • Insights from the AHA about ICD-10 transitions for every size organization
  • Retaining clinical and financial information in the transition
  • The impact of ICD-10 on healthcare quality data

Over 20 industry experts from leading health consulting and technology solutions firms will be participating, including:

  • No World Borders, Inc.
  • 3M Health Information Systems, Inc.
  • Partners Healthcare
  • Perot Systems
  • Ingenix
  • The TriZetto Group
  • GE Healthcare Systems, Centricity Enterprise Div
  • Deloitte Consulting LLP
  • American Hospital Association
  • Capgemini Government Solutions LLC

Registration Information for the Event is Available at
Dates: February 18th & 19th

Location: Atlanta, Georgia
Conference Registration: $1,395.00

More information regarding No World Borders and its HIPAA X12 5010 and ICD-10 Migration Services and Consulting Practice is available on the company web site :
A free information brief is also available in Adobe Acrobat format:

Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See and for more about the company.

Leave a Reply